Dr John Henry Pokorny, MD | |
1245 Highland Ave, Suite G-05, Abington, PA 19001-3714 | |
(215) 884-2880 | |
(215) 885-9768 |
Full Name | Dr John Henry Pokorny |
---|---|
Gender | Male |
Speciality | Plastic Surgery |
Location | 1245 Highland Ave, Abington, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831109206 | NPI | - | NPPES |
0802867000 | Other | PA | AMERIHEALTH |
777940 | Other | PA | HIGHMARK BLUE SHIELD |
00802867000 | Other | PA | INDEPENDENCE BLUE CROSS |
0802867000 | Other | PA | KEYSTONE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | MD-047352L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John Henry Pokorny, MD 1245 Highland Ave, Suite G-05, Abington, PA 19001-3714 Ph: (215) 884-2880 | Dr John Henry Pokorny, MD 1245 Highland Ave, Suite G-05, Abington, PA 19001-3714 Ph: (215) 884-2880 |
News Archive
CombinatoRx, Incorporated, today announced that its ophthalmic collaborator, Fovea Pharmaceuticals SA, has entered into a proposed acquisition with Sanofi-Aventis. A CombinatoRx-derived combination drug candidate, Prednisporin, (FOV1101), which is a fixed dose combination of prednisolone and cyclosporine, is the most advanced product asset in the Fovea pipeline, with Phase 2b clinical studies planned for the treatment of persistent allergic conjunctivitis.
Benitec has announced an exclusive licensing deal with Stanford University. Under the license, Benitec receives exclusive rights to use the Minicircle DNA technology pioneered at Stanford University for all RNAi therapeutic uses, with sub-licensing rights.
Providing women who take a powerful acne drug with a fact sheet about contraception while visiting the dermatologist can significantly improve their awareness of the most effective birth control options and may prevent unintended pregnancies and birth defects that can be caused by the drug, according to a University of Pittsburgh School of Medicine study published Feb. 4 in the journal JAMA Dermatology.
During the first year of life, the human brain doubles in size, and continues growing through adolescence.
› Verified 9 days ago